Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MCD Versus FMD in Untreated Advanced Follicular Lymphoma
NCT00006250Phase 3Unknown
- Sponsor
- Lymphoma Trials Office
- Start
- May 2000
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of chlorambucil, fludarabine in follicular lymphoma (FL), sponsored by Lymphoma Trials Office. Status: unknown.
02
Drugs
chlorambucilfludarabine
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00006250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006250.